← Open Payments lookup

ERIN PERDUE: Open Payments

NPI 1275949455 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$996 in 41 payments from 16 companies in 2025. Trend: 2023 $1,622 · 2024 $1,767 · 2025 $996

Food & beverage: $943Education: $53
CompanyPaymentsAmount
GlaxoSmithKline, LLC.7$164
Regeneron Healthcare Solutions, Inc.6$144
GENZYME CORPORATION4$116
Verona Pharma, Inc.5$107
Amgen Inc.3$74
Actelion Pharmaceuticals US, Inc.3$70
AstraZeneca Pharmaceuticals LP3$60
SANOFI-AVENTIS U.S. LLC1$53
United Therapeutics Corporation2$48
Takeda Pharmaceuticals U.S.A., Inc.1$34

Products named: DUPIXENT, NUCALA, Ohtuvayre, TEZSPIRE, Tyvaso, OPSUMIT, FASENRA, GLASSIA.

Industry payments across MD — which companies pay providers there.